ARLP Q1 2026 Earnings EPS Beat by 3 Amid Solid Operational Performance XCUR Q2 2022 Earnings EPS Misses Estimates as ClinicalStage Biotech Reports No Revenue MSA Safety MSA Q1 2026 Earnings EPS Beats Estimates by Nearly 8 Shares Edge Higher JILL Q1 2026 Earnings NarrowerLoss Beat Drives Modest Share Uptick BHFAM Q1 2026 Earnings Preferred Stock EPS Falls Short of Expectations Amid Mixed Operating Environment Xenetic Biosciences Q2 2025 Earnings Narrowed Loss Exceeds Expectations Amid Oncology Pipeline Progress